Carey, Caitlin E. http://orcid.org/0000-0002-4953-5351
Shafee, Rebecca http://orcid.org/0009-0007-1897-3272
Wedow, Robbee http://orcid.org/0000-0002-3108-7087
Elliott, Amanda
Palmer, Duncan S. http://orcid.org/0000-0002-0824-0047
Compitello, John
Kanai, Masahiro http://orcid.org/0000-0001-5165-4408
Abbott, Liam
Schultz, Patrick
Karczewski, Konrad J. http://orcid.org/0000-0003-2878-4671
Bryant, Samuel C. http://orcid.org/0009-0001-9891-0488
Cusick, Caroline M.
Churchhouse, Claire http://orcid.org/0000-0003-3140-6452
Howrigan, Daniel P. http://orcid.org/0000-0002-7721-4838
King, Daniel
Davey Smith, George http://orcid.org/0000-0002-1407-8314
Neale, Benjamin M. http://orcid.org/0000-0003-1513-6077
Walters, Raymond K. http://orcid.org/0000-0001-8422-6530
Robinson, Elise B. http://orcid.org/0000-0003-2314-2792
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH124851, 5R37MH107649, R01MH101244, R01MH124851)
Stanley Center for Psychiatric Research
RW’s work is supported by AnalytiXIN, which is primarily funded through the Lilly Endowment, IU Health and Eli Lilly and Company.
Novo Nordisk Fonden (NNF21SA0072102)
Article History
Received: 26 October 2022
Accepted: 14 May 2024
First Online: 4 July 2024
Competing interests
: C.E.C. is currently an employee of Novartis. R.W. is a research fellow at AnalytiXIN, which is a consortium of health-data organizations, industry partners and university partners in Indiana primarily funded through the Lilly Endowment, IU Health and Eli Lilly and Company. B.M.N. is a member of the scientific advisory board at Deep Genomics and Neumora, and a consultant of the scientific advisory board of Camp4 Therapeutics. R.K.W. has received honoraria from the Jackson Laboratory and sponsored travel from the Russell Sage Foundation in the past 36 months. G.D.S. reports Scientific Advisory Board Membership for Relation Therapeutics and Insitro. The remaining authors declare no competing interests.